What is Alnylam Pharmaceuticals's roche technology transfer obligation — transaction price?

Alnylam Pharmaceuticals (ALNY) reported roche technology transfer obligation — transaction price of $2.00M in Q1 2026.

Roche Technology Transfer Obligation — Transaction price

Alnylam Pharmaceuticals Roche Technology Transfer Obligation — Transaction price remained flat by 0.0% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.00M to $2.00M.

Analysis

StatementSegment

First reportedQ3 2023

Last reportedQ1 2026

Metric ID: alny_segment_roche_technology_transfer_obligation_transaction_price

Historical Data

7 periods

	Q3 '23	Q4 '23	Q4 '24	Q1 '25	Q2 '25	Q4 '25	Q1 '26
Value	$2.00M	$2.00M	$2.00M	$2.00M	$2.00M	$2.00M	$2.00M
QoQ Change	—	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
YoY Change	—	—	+0.0%	—	—	+0.0%	+0.0%

Range$2.00M – $2.00M

CAGR+0.0%

Avg YoY Growth+0.0%

Median YoY Growth+0.0%

Current Streak6+ quarters growth

Frequently Asked Questions

What is Alnylam Pharmaceuticals's roche technology transfer obligation — transaction price?: Alnylam Pharmaceuticals (ALNY) reported roche technology transfer obligation — transaction price of $2.00M in Q1 2026.
How has Alnylam Pharmaceuticals's roche technology transfer obligation — transaction price changed year-over-year?: Alnylam Pharmaceuticals's roche technology transfer obligation — transaction price decreased by 0.0% year-over-year, from $2.00M to $2.00M.